Alcohol-related liver disease affects far more Americans than previously recognized, with new research showing that people systematically underreport their drinking to doctors, masking the true scale of the problem. A comprehensive analysis of U.S. health data from 1988 to 2023 found that when researchers corrected for this underreporting, the prevalence of alcohol-related liver disease (ALD) jumped from 1.65% to 4.59% of the adult population, and metabolic dysfunction-associated alcohol-related liver disease (MetALD) nearly doubled from 2.14% to 4.10% . This hidden burden has serious consequences: people with alcohol-related liver disease face premature death rates nearly 3 times higher than those without liver disease.

Why Are People Hiding Their Drinking From Doctors?

The gap between what people actually drink and what they tell their doctors is enormous. Researchers from the Center for Outcomes Research in Liver Disease analyzed data from over 41,100 adults and discovered that alcohol consumption is systematically underreported due to recall bias and social stigma . When people minimize their drinking during medical visits, they get misclassified as having metabolic dysfunction-associated steatotic liver disease (MASLD), a condition linked to obesity and metabolic problems, rather than alcohol-related liver disease. This misclassification has real consequences: it obscures the true burden of alcohol-related liver disease, skews mortality estimates, and sends public health resources in the wrong direction.

The problem is particularly acute with binge drinking. Binge drinking, defined as consuming five or more drinks on a single occasion at least once in the past year, emerged as the dominant driver of premature death in both MetALD and ALD cases . Among people with alcohol-related liver disease, binge drinking accounted for 92.85% of premature mortality risk, making it the single most important factor determining who dies early from liver disease.

What Happens When Alcohol and Diabetes Collide?

The research uncovered a dangerous combination: people with both binge drinking and type 2 diabetes faced the greatest mortality risks . Type 2 diabetes was the strongest metabolic predictor of premature death in people with MASLD, accounting for between 13.25% and 44.80% of the mortality burden. But when diabetes combined with alcohol use, the risk multiplied. Similarly, people with binge drinking and hypertension (high blood pressure) also faced significantly elevated death rates.

The premature mortality rates tell a stark story. People with alcohol-related liver disease experienced 14.91 deaths per 1,000 person-years of follow-up, compared to just 4.76 deaths per 1,000 person-years among people without liver disease . Those with MetALD faced 8.74 deaths per 1,000 person-years, and even people with MASLD alone experienced 7.86 deaths per 1,000 person-years. In other words, having any form of steatotic liver disease substantially shortened life expectancy.

How to Protect Your Liver If You Drink Alcohol

Get Honest About Your Drinking: Track how many drinks you actually consume per week and per occasion, then share this accurate number with your doctor. Underreporting prevents early detection of liver damage and allows disease to progress silently.
Avoid Binge Drinking Patterns: Instead of spreading drinks throughout the week, binge drinking (five or more drinks in one sitting) causes acute liver injury and was the dominant driver of premature death in the study population.
Monitor for Metabolic Risk Factors: If you drink regularly, get screened for type 2 diabetes and hypertension, as these conditions dramatically amplify liver disease risk when combined with alcohol use.
Request Liver Function Testing: Ask your doctor to check your liver enzymes (ALT and AST) and consider ultrasound screening if you have risk factors, since early detection can prevent progression to cirrhosis.

Is the Problem Getting Worse?

Yes. The research documented a troubling upward trend across all forms of steatotic liver disease over the past 35 years. MASLD prevalence increased from 12.69% in 1988-1990 to 28.16% in 2021-2023 . MetALD rose from 1.62% to 4.10%, and ALD climbed from 2.28% to 4.59%. These increases reflect changing social norms around drinking, greater alcohol availability, and rising rates of obesity and type 2 diabetes, particularly among younger adults. The researchers noted that emerging evidence suggests a shift toward younger age at onset for alcohol-related liver disease, reflecting increased binge drinking in younger populations.

The economic and public health implications are staggering. Alcohol-related liver disease remains the leading cause of cirrhosis, liver-related mortality, and liver transplantation in both the United States and Europe, despite being reported as affecting only about 1% of the population . This paradox, between low reported prevalence and high disease burden, is largely explained by the systematic underreporting of alcohol consumption that the new research quantifies.

What Should Public Health Do Differently?

The researchers emphasized the urgent need for targeted interventions. Their findings underscore the importance of systematic screening for alcohol consumption, particularly binge drinking, as part of routine medical care . They also called for comprehensive assessment of cardiometabolic risk factors like diabetes and hypertension in people who drink. Educational initiatives are needed to increase awareness of how alcohol use and type 2 diabetes interact to accelerate liver disease progression and worsen outcomes.

The bottom line: alcohol-related liver disease is far more common than official statistics suggest, binge drinking is the primary driver of premature death, and the combination of alcohol use with metabolic conditions like diabetes creates a particularly dangerous situation. If you drink, being honest with your doctor about how much and how often could be the difference between catching liver disease early and developing irreversible cirrhosis.

" }